Zydus Cadila posted a 41 per cent hike in net profit for the year ended March 31 to Rs 711 crore compared to the year before. The group registered a total income from operations of Rs 4630 crore, up 26 per cent from Rs 3687 crore crores in the corresponding period last year on a consolidated basis.
The topline growth was primarily driven by 37 per cent growth in formulation exports and 19 per cent growth in India formulations business, 25 per cent growth in its consumer business and 18 per cent growth in active pharmaceutical ingredients (API) exports.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
